{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:05:58Z","timestamp":1789758358241,"version":"4.0.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-NS050895"],"award-info":[{"award-number":["R01-NS050895"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01-AG020241"],"award-info":[{"award-number":["R01-AG020241"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U01-AG048310"],"award-info":[{"award-number":["U01-AG048310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P50-AG016573"],"award-info":[{"award-number":["P50-AG016573"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RF1-AG048099"],"award-info":[{"award-number":["RF1-AG048099"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.03.020","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T06:31:52Z","timestamp":1489818712000},"page":"2015-2024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Hayk","family":"Davtyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley W.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Zagorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Petrushina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Kazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Cribbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Agadjanyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Blurton-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahit","family":"Ghochikyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.020_b0005","unstructured":"Dementia, Fact Sheet. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs362\/en\/>; [April, 2016]."},{"key":"10.1016\/j.vaccine.2017.03.020_b0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2017.03.020_b0015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-8993(91)91553-D","article-title":"In vitro aging of \u03b2-amyloid protein causes peptide aggregation and neurotoxicity","volume":"563","author":"Pike","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.vaccine.2017.03.020_b0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.03.020_b0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.med.45.1.435","article-title":"Cellular and molecular biology of Alzheimer's disease and animal models","volume":"45","author":"Price","year":"1994","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2017.03.020_b0035","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/nature07767","article-title":"APP binds DR6 to trigger axon pruning and neuron death via distinct caspases","volume":"457","author":"Nikolaev","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2017.03.020_b0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.03.020_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fneur.2013.00093","article-title":"Formation and propagation of tau oligomeric seeds","volume":"4","author":"Gerson","year":"2013","journal-title":"Front Neurol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bpa.12044","article-title":"\u201cPrion-like\u201d templated misfolding in tauopathies","volume":"23","author":"Clavaguera","year":"2013","journal-title":"Brain Pathol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","article-title":"Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo","volume":"80","author":"Yanamandra","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.vaccine.2017.03.020_b0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrn2786","article-title":"Prion-like mechanisms in neurodegenerative diseases","volume":"11","author":"Frost","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0075","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/archneur.63.10.1459","article-title":"Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein","volume":"63","author":"Rosenmann","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/alzrt278","article-title":"First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer's disease model","volume":"6","author":"Kontsekova","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.vaccine.2017.03.020_b0085","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","article-title":"Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements","volume":"27","author":"Asuni","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0090","doi-asserted-by":"crossref","first-page":"16559","DOI":"10.1523\/JNEUROSCI.4363-10.2010","article-title":"Immunotherapy targeting pathological tau prevents cognitive decline in a new tangle mouse model","volume":"30","author":"Boutajangout","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0095","doi-asserted-by":"crossref","first-page":"e26860","DOI":"10.1371\/journal.pone.0026860","article-title":"Tau-targeted immunization impedes progression of neurofibrillary histopathology in aged P301L tau transgenic mice","volume":"6","author":"Bi","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.020_b0100","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.expneurol.2010.05.010","article-title":"Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice","volume":"224","author":"Boimel","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0105","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2174\/156720512800492503","article-title":"Targeting phospho-Ser422 by active Tau immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach","volume":"9","author":"Troquier","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.vaccine.2017.03.020_b0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1742-2094-10-150","article-title":"Immunomodulation targeting of both A\u03b2 and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models","volume":"10","author":"Goni","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.vaccine.2017.03.020_b0115","doi-asserted-by":"crossref","first-page":"e72301","DOI":"10.1371\/journal.pone.0072301","article-title":"Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy","volume":"8","author":"Theunis","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.020_b0120","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4161\/hv.23875","article-title":"Refinement of a DNA based Alzheimer's disease epitope vaccine in rabbits","volume":"9","author":"Ghochikyan","year":"2013","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.vaccine.2017.03.020_b0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jalz.2013.04.505","article-title":"Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques","volume":"10","author":"Evans","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.vaccine.2017.03.020_b0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jalz.2013.12.003","article-title":"The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates","volume":"10","author":"Davtyan","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.vaccine.2017.03.020_b0135","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/1566523214666140522121427","article-title":"BTX AgilePulse(TM) system is an effective electroporation device for intramuscular and intradermal delivery of DNA vaccine","volume":"14","author":"Davtyan","year":"2014","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.vaccine.2017.03.020_b0140","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/BST20120134","article-title":"Tau oligomers and tau toxicity in neurodegenerative disease","volume":"40","author":"Ward","year":"2012","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.vaccine.2017.03.020_b0145","doi-asserted-by":"crossref","first-page":"12776","DOI":"10.1523\/JNEUROSCI.3463-09.2009","article-title":"Axonal transport defects in neurodegenerative diseases","volume":"29","author":"Morfini","year":"2009","journal-title":"J Neurosci"},{"issue":"826","key":"10.1016\/j.vaccine.2017.03.020_b0150","first-page":"e15","article-title":"Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport","volume":"33","author":"Kanaan","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.vaccine.2017.03.020_b0155","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1038\/srep09659","article-title":"Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms","volume":"5","author":"Derisbourg","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.03.020_b0160","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1021\/bi0272510","article-title":"Tau polymerization: role of the amino terminus","volume":"42","author":"Gamblin","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2017.03.020_b0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2353\/ajpath.2006.060002","article-title":"Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits","volume":"169","author":"Schindowski","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/intimm\/dxg049","article-title":"Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with \u03b2-amyloid","volume":"15","author":"Cribbs","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0175","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1523\/JNEUROSCI.3201-07.2007","article-title":"Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble\/oligomeric A\u03b2 species in amyloid precursor protein transgenic mice","volume":"27","author":"Petrushina","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0180","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1523\/JNEUROSCI.4672-12.2013","article-title":"Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial","volume":"33","author":"Davtyan","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0185","doi-asserted-by":"crossref","first-page":"28912","DOI":"10.1038\/srep28912","article-title":"Alzheimer's disease Advax(CpG)- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and A\u03b2 pathological molecules","volume":"6","author":"Davtyan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2017.03.020_b0190","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.03.020_b0195","doi-asserted-by":"crossref","first-page":"E1316","DOI":"10.1073\/pnas.1525466113","article-title":"The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function","volume":"113","author":"Marsh","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2017.03.020_b0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.iy.08.040190.001511","article-title":"Lymphokine control of in vivo immunoglobulin isotype selection","volume":"8","author":"Finkelman","year":"1990","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0205","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jalz.2015.06.1884","article-title":"A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease","volume":"11","author":"Agadjanyan","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.vaccine.2017.03.020_b0210","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11481-015-9637-6","article-title":"Tau-directed immunotherapy: a promising strategy for treating Alzheimer's disease and other tauopathies","volume":"11","author":"Schroeder","year":"2016","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.020_b0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2017.03.020_b0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.expneurol.2013.07.006","article-title":"Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation","volume":"248","author":"Rozenstein-Tsalkovich","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/515613","article-title":"First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response","volume":"178","author":"MacGregor","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.020_b0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical applications of DNA vaccines: current progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.020_b0235","doi-asserted-by":"crossref","first-page":"e59340","DOI":"10.1371\/journal.pone.0059340","article-title":"DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial","volume":"8","author":"Graham","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.020_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-4598-10-3","article-title":"Improvement of different vaccine delivery systems for cancer therapy","volume":"10","author":"Bolhassani","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1016\/j.vaccine.2017.03.020_b0245","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1523\/JNEUROSCI.1988-04.2004","article-title":"Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease","volume":"24","author":"Horowitz","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0250","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1523\/JNEUROSCI.0560-11.2011","article-title":"Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases","volume":"31","author":"Kanaan","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.vaccine.2017.03.020_b0255","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","article-title":"Human secreted tau increases amyloid-\u03b2 production","volume":"36","author":"Bright","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.vaccine.2017.03.020_b0260","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00702-014-1315-y","article-title":"Passive immunization targeting the N-terminal projection domain of tau decreases tau pathology and improves cognition in a transgenic mouse model of Alzheimer disease and tauopathies","volume":"122","author":"Dai","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.vaccine.2017.03.020_b0265","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/acn3.176","article-title":"Anti-tau antibody reduces insoluble tau and decreases brain atrophy","volume":"2","author":"Yanamandra","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.vaccine.2017.03.020_b0270","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1523\/JNEUROSCI.3192-13.2014","article-title":"Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles","volume":"34","author":"Castillo-Carranza","year":"2014","journal-title":"J Neurosci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T07:58:17Z","timestamp":1535961497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":54,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17303262"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}